TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Primex Pharmaceuticals Oy
Closing information (x1000 DKK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
4,810
|
38,341
|
9,909 |
Financial expenses |
2,766
|
209
|
558 |
Earnings before taxes |
-8,237
|
4,701
|
-3,119 |
Total assets |
92,291
|
49,818
|
32,751 |
Current assets |
21,203
|
19,066
|
5,040 |
Current liabilities |
2,885
|
7,776
|
4,214 |
Equity capital |
52,234
|
42,042
|
28,545 |
- share capital |
22
![]() |
22
![]() |
22 |
Employees (average) | 6 | 6 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
56.6%
|
84.4%
|
87.2% |
Turnover per employee | 802 | 1,652 | |
Profit as a percentage of turnover |
-171.2%
|
12.3%
|
-31.5% |
Return on assets (ROA) |
-5.9%
|
9.9%
|
-7.8% |
Current ratio |
734.9%
|
245.2%
|
119.6% |
Return on equity (ROE) |
-15.8%
|
11.2%
|
-10.9% |
Change turnover |
-33,388
|
28,409
|
5,547 |
Change turnover % |
-87%
|
286%
|
127% |
Chg. No. of employees | 1 | ||
Chg. No. of employees % | 20% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.